Moreover, PDAC is characterized by tumor-infiltrating CD4+ and CD8+ T-cells; however, as PDAC progresses, the percentage of Tregs elevates within the CD4+ T-cell subset, while CD8+ T-cells shift in a decreased composition [21,22]. The gene discussed is CD4; the disease is neoplasm.